Skip to main content
. 2021 Mar 10;4(1):293–312. doi: 10.1007/s42247-021-00192-8

Fig. 6.

Fig. 6

Pro-sensing biohybrids for the generation of accelerated anti-viral immunity applicable to the first sensory interface between the host and SARS-CoV-2